- Category
- Small (2023-24)
- Udyam number
- UDYAM-UK-05-0005649

About Quasar Labs Private Limited
Data last updated:
Quasar Labs Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Solvate Laboratories Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 July 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG2005PTC046815. Its GSTIN is 05AAACQ1325R1ZB (Uttarakhand). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹25 Lakh. It is led by directors including Sanjay Kumar and Om Prakash.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 3 – 5 – 65/9 Ground Floor Behind Vinayak Park Vivekanandanagar Colony Kukatpally, Hyderabad, Telangana, India – 500072.
As per the financials filed for FY 2024, the company reported a revenue of ₹16.23 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹1.24 Cr (net margin 7.7%) and EBITDA of ₹1.97 Cr (EBITDA margin 12.1%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years.
The company has about 72 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹2.35 Cr on record. Court records list 10 cases involving the company, including 7 filed by the company and 3 filed against it; 8 cases are pending.
Quasar Labs Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-05-0005649). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website solvatelab.com.
Company details
CIN history
Quasar Labs has one previous CIN (Corporate Identification Number): U24230AP2005PTC046815. The current CIN is U24230TG2005PTC046815, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230TG2005PTC046815 | Current |
| U24230AP2005PTC046815 | Previous |
Recognitions & Rankings of Quasar Labs
Contact details
Quasar Labs Private Limited's registered office is in Hyderabad, Telangana. Its website is solvatelab.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address3 – 5 – 65/9 Ground Floor Behind Vinayak Park Vivekanandanagar Colony Kukatpally, Hyderabad, Telangana, India – 500072
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Quasar Labs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Quasar Labs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Quasar Labs Private Limited, buy the company report.
Financials of Quasar Labs Private Limited
FY 2024 filings availableQuasar Labs Private Limited reported revenue of ₹16.23 Cr (up 7% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 8% over three years, including 7% growth in the latest year. EBITDA rose 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹16.23 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.97 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.24 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.1% | ||||
| Net Profit Margin | 7.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Quasar Labs Private Limited, buy the company report.
Board of directors of Quasar Labs Private Limited
Quasar Labs has 7 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjay Kumar | Director | 09 Nov 2009 | 16 Years 11 Months | Current |
| Om Prakash | Director | 12 Aug 2013 | 13 Years 2 Months | Current |
| Yogendra Kumar Also directs: Solvate Laboratories Private Limited, Unistar Biotech Limited, Soltech Infra Private Limited and 3 more | Director | 09 Nov 2009 | 16 Years 11 Months | Current |
| Shailendra Kumar | Director | 12 Aug 2013 | 13 Years 2 Months | Current |
| Pawan Kumar Singh | Director | 12 Aug 2013 | 13 Years 2 Months | Current |
| Aseem Kumar Also directs: Solvate Laboratories Private Limited, Unistar Biotech Limited, Soltech Infra Private Limited and 3 more | Director | 12 Aug 2013 | 13 Years 2 Months | Current |
Peer comparison
Quasar Labs Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Adaarsh Pharmacon Industries Private Limited | ₹16.37 Cr (FY 2024) | 449.0% | Gulbarga, Karnataka, India | |||
| Nutra Life Healthcare Private Limited | ₹16.34 Cr (FY 2025) | 5.0% | Roorkee, Uttarakhand, India | |||
| Jash Pharma Private Limited | ₹16.28 Cr (FY 2021) | 24.0% | Mumbai, Maharashtra, India | |||
| Quasar Labs Private Limitedthis company | ₹16.23 Cr (FY 2024) | ₹1.24 Cr | 7.7% | 7.0% | 72 | Hyderabad, Telangana, India |
| Aleor Dermaceuticals Limited | ₹16.23 Cr (FY 2021) | 308.0% | Vadodara, Gujarat, India | |||
| Paramount Pesticides Limited | ₹16.22 Cr (FY 2025) | -7.0% | Meerut, Uttar Pradesh, India | |||
| Magnus Biotech Private Limited | ₹16.13 Cr (FY 2025) | 5.0% | Village Kunjpura, Haryana, India | |||
| Sunways Rohto Pharmaceutical Private Limited | ₹16.12 Cr (FY 2025) | 17.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Quasar Labs Private Limited, buy the company report.
Auditor
Quasar Labs Private Limited is audited by H K N C AND COMPANY for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| H K N C AND COMPANY | FY 2024 | 029304N |
Shareholding
The shareholding of Quasar Labs Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Quasar Labs Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Mar 2021 | 100434603 | Hdfc Bank Limited | ₹1.5 Cr | Open | |
| 18 Dec 2012 | 10397219 | Bank of Baroda | ₹85 Lakh | Open |
To see the full charge records of Quasar Labs Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Quasar Labs Private Limited has 10 court cases on record: 7 filed by Quasar Labs, 3 filed against it. 8 cases are pending and 2 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 9 | 3 | 8 |
| High courts | 1 | 0 | 0 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Dehradun, Uttarakhand | Criminal case | Filed by the company against Sain Bio Med Pvt Ltd | Pending |
| District court, Dehradun, Uttarakhand | Criminal case | Filed by the company against Reeveet Pharma Pvt Ltd and Others | Pending |
| District court, Warangal, Telangana | Criminal complaint | Filed against the company by The State of Telangana Through the Drugs Inspector, Warangal | Pending |
| District court, DAKSHINA KANNADA, Karnataka | Criminal complaint | Filed against the company by State at the Instance of Assistant Drugs Controller | Pending |
| District court, Dehradun, Uttarakhand | Criminal case | Filed by the company against Sainbio Med Pvt Ltd | Pending |
To see the full case history of Quasar Labs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Quasar Labs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Quasar Labs Private Limited has a workforce of 72 employees on its EPFO records as of Mar 11, 2025, across 1 active EPFO establishment.
GST
Quasar Labs has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAACQ1325R1ZB | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Quasar Labs Private Limited, buy the company report.
Recent activity
Quasar Labs Private Limited has 14 board changes on record since 2009: 7 appointments and 7 cessations. The latest: Sanjay Kumar ceased to be Additional Director on 29 Sep 2016.
8 earlier events are in the company report.
Frequently asked questions
Quasar Labs is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 July 2005 (21+ years old) and is registered under CIN U24230TG2005PTC046815.
Quasar Labs has 7 current directors:
- Sanjay Kumar - Director
- Om Prakash - Director
- Yogendra Kumar - Director
- Shailendra Kumar - Director
- Pawan Kumar Singh - Director
- Aseem Kumar - Director
- Amit Kumar Pandey - Director
The latest financial statements of Quasar Labs on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Quasar Labs is 05AAACQ1325R1ZB, registered in Uttarakhand. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Quasar Labs is U24230TG2005PTC046815. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Quasar Labs has 10 court cases on record: 7 filed by the company and 3 filed against it. 8 are pending. Most are in the district courts.
Quasar Labs was incorporated on 11 July 2005, making it 21+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Quasar Labs by revenue are Adaarsh Pharmacon Industries Private Limited, Nutra Life Healthcare Private Limited, Jash Pharma Private Limited, Aleor Dermaceuticals Limited, Paramount Pesticides Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sanjay Kumar ceased to be Additional Director on 29 Sep 2016. Yogendra Kumar ceased to be Additional Director on 29 Sep 2016. Amit Kumar Pandey was appointed as Director on 12 Aug 2013. Quasar Labs has 14 board changes on record in total.
Yes, Quasar Labs is registered as a small enterprise under Udyam registration (number: UDYAM-UK-05-0005649).
Quasar Labs can be reached through the website solvatelab.com. Its registered office is in Hyderabad, Telangana, India.